Partnering Solutions

81. Your Trusted Packaging And Serialization Partner 2/6/2018

    How your manufacturing, packaging, serialization, and clinical distribution can benefit with a contract partner.

82. Cell & Gene Therapy Solutions 9/29/2023

    Your therapy can make all the difference. Together, we’ll unlock its potential.

83. Isotope Labelling 3/3/2022

    Whether you need isotopically labelled (14C/SIL) compounds for nonclinical or clinical metabolism studies and the quantification of materials in biological matrices, our expertise provides the necessary labelled materials tailored to support your studies.

84. eTMF: Promising Accessibility, Compliance, And More 5/28/2024

    Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.

85. Rave TSDV - Improve CRA Efficiency And Reduce Site Burden 12/20/2023

    Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.

86. Your Partner In Psychiatry Research 7/18/2024

    Our extensive network of specialized Healthcare-First psychiatry research sites is dedicated to advancing psychiatric care through cutting-edge clinical studies.

87. GxP Quality Assessment And Remediation 9/16/2024

    Ensure regulatory compliance and foster continuous improvement through the use of comprehensive GxP quality assessment and remediation services.

88. Advancing Development And Approval Of Rare/Ultra-Rare Disease Therapies 5/8/2024

    Veristat empowers rare disease therapy with science-driven strategies and trusted expertise, supporting over 350 rare disease projects and preparing 40+ marketing applications in the past five years.

89. GMO Solutions 6/27/2023

    Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).

90. Liver Disease CRO Services 11/7/2023

    Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.